What's in BeBetter Med Inc's pipeline?

BeBetter Med Inc has 8 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 3 in Phase 2, 1 in Phase 1.

Which companies overlap with BeBetter Med Inc's portfolio?

Top competitors by shared drug class: University of California, San Diego, Hanmi Pharmaceutical Company Limited, Second Affiliated Hospital, School of Medicine, Zhejiang University, Sun Pharma Advanced Research Company Limited, AceLink Therapeutics, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/bebetter-med-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

BeBetter Med Inc — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

BeBetter Med Inc pipeline: 0 marketed, 0 filed, 4 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 3 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
BEBT-209 capsules	BEBT-209 capsules	phase 3	SGLT2 inhibitor	SGLT2	Diabetes
BEBT-209 Placebo capluses	BEBT-209 Placebo capluses	phase 3
Ifosfamide for Injection	Ifosfamide for Injection	phase 3	Alkylating agent	DNA (non-specific cross-linking)	Oncology
Ifupinostat Hydrochloride for Injection	Ifupinostat Hydrochloride for Injection	phase 3	Histone deacetylase (HDAC) inhibitor	Histone deacetylase (HDAC)	Oncology

Therapeutic area mix

Oncology · 2
Diabetes · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

University of California, San Diego · 2 shared drug classes
Hanmi Pharmaceutical Company Limited · 2 shared drug classes
Second Affiliated Hospital, School of Medicine, Zhejiang University · 2 shared drug classes
Sun Pharma Advanced Research Company Limited · 2 shared drug classes
AceLink Therapeutics, Inc. · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
AJU Pharm Co., Ltd. · 1 shared drug class
Abbott · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for BeBetter Med Inc:

Cite this brief

Drug Landscape (2026). BeBetter Med Inc — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/bebetter-med-inc. Accessed 2026-06-10.